Less Ads, More Data, More Tools Register for FREE

Pin to quick picksDistrib. Fin. Regulatory News (DFCH)

Share Price Information for Distrib. Fin. (DFCH)

Share Price is delayed by 15 minutes
Get Live Data
54.50    0.50 (0.93%)
Bid:
54.00
Ask:
55.00
Spread: 1.00 (1.852%)
Market Cap: £89.43m
DFCH Live PriceLast checked at - London Stock Exchange

Intraday Distrib. Fin. Share Chart

Trading Statement

29 Nov 2023 07:00

RNS Number : 9709U
Distribution Finance Cap. Hldgs PLC
29 November 2023
Β 

This announcement contains inside information as stipulated under the UK version of the Market Abuse Regulation (EU no. 596/2014) as it forms part of UK law by virtue of the European Union (Withdrawal) Act 2018 (as amended from time to time).

Β 

29 November 2023

Β 

Distribution Finance Capital Holdings plc

("DF Capital" or the "Company" together with its subsidiaries the "Group")

Β 

Β 

Trading and Capital Strategy Update

Β 

Distribution Finance Capital Holdings plc, a specialist bank providing working capital solutions to dealers and manufacturers across the UK, provides an update in relation to its single large obligor arrears balance, a trading update and a change to its medium-term capital strategy.

Update relating to large single obligor's arrears balance

The Group previously reported that as at 30 June 2023 the Group's arrears included Β£10.4m of balance outstanding in respect of a large single obligor; RoyaleLife and associated companies ("RoyaleLife"), a customer of the Company since June 2018, representing c.2 per cent of the Group's loan book as at 30 September 2023. Whilst the refinancing and restructuring of RoyaleLife was in progress, it had been delayed, and at that time the Group's assessment, following engagement with key stakeholders, was that the Group would be repaid should the proposed refinance complete as planned.

The Group is aware of a significant number of assets which have been sold out of trust or are missing from confirmed locations and following continued work with various stakeholders, it is now clear that RoyaleLife's financial situation and operation is much opaquer and more complex than originally determined, adversely impacting, to a greater degree than expected, a larger number of secured lenders and other creditors.

Whilst the Group understands that action to refinance RoyaleLife remains in progress, there is no certainty at this stage given the elapsed time and new information that this will lead to a satisfactory outcome and successful refinance, which will see the Group being substantively repaid.

Whilst the Group will continue to work with stakeholders to effect a good outcome, pursuing recovery of the outstanding debt to the fullest extent possible, the Group intends to make an appropriate credit loss provision in its full year accounts for the year ending 31 December 2023. Due to the unique circumstances associated with RoyaleLife and the one-off nature of any provision, the Group does not anticipate any further impact to its results for the next financial year ending 31 December 2024.

The Group maintains a highly cautious and vigilant approach to credit risk management and the circumstances surrounding RoyaleLife facility are unique in the context of the Group's loan book.Β 

Trading update and capital strategy

As reported in the results for six months ended 30 June 2023 the Group delivered pre-tax profit, including impairment provisions, of Β£3.2m in the first half, more than the entire previous financial year. Additionally, new loan origination remained strong, stock turn extended further and the Group continued to generate elevated net interest margin. However, in light of any expected credit loss provision in relation to RoyaleLife, the Group now expects to deliver a pre-tax profit of no less than Β£2.0m for the year ending 31 December 2023.

Given the strong underlying momentum combined with the Group's expectations of further loan book growth, the Company has determined that, in the medium term, it will remain flexible and pragmatic in the pursuit of its growth strategy, balancing this against its ability to generate retained earnings as a route to organic capital accretion.

As previously announced the Group believes it has capacity to grow its current loan book to the envisaged level of approximately Β£800m based on current capital, a full drawdown of the Β£20m Tier 2 Capital Facility as announced on 8 September 2023 and upsizing of the previously announced ENABLE Guarantee from Β£250m to Β£350m. At a cΒ£800m loan book the financial characteristics of the Group would allow it to achieve further organic growth at a slower, but healthy rate without the need to raise additional Tier 1 capital. The Group remains committed to becoming a multi-product lender in the near-term, considering organic and inorganic product development strategies which underpin the Group's longer-term earnings potential.

Β 

Carl D'Ammassa, Chief Executive, commented: "Despite our best efforts, it is very disappointing that we have not been able to resolve the RoyaleLife situation. This is a complex, demanding and unique exposure that we have been working through over many months alongside other lenders and creditors. Despite the material changes to the landscape most recently, we continue to seek recovery, but feel prudency and transparency of approach is critical at this time and central to our model".

Β 

"Notwithstanding this situation, the Group is seeing strong underlying financial momentum and we remain well placed to build a diverse multi-product lending proposition, without the pressing need to raise Tier 1 capital through an equity raise."

Β 

The person responsible for arranging the release of this announcement on behalf of the Company is Karen D'Souza (Company Secretary).

Β 

For further information contact:

Distribution Finance Capital Holdings plc

Carl D'Ammassa - Chief Executive Officer

+44 (0) 161 413 3391

Kam Bansil - Head of Investor Relations

+44 (0) 7779 229508

http://www.dfcapital-investors.com

Investec Bank plc (Nomad and Joint Broker)

+44 (0) 207 597 5970

David Anderson

Bruce Garrow

Harry Hargreaves

Maria Gomez de Olea

Liberum Capital Limited (Joint Broker)

+44 (0) 203 100 2000

Chris Clarke

Lauren Kettle

Β 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
Β 
END
Β 
Β 
TSTZZMZMRRRGFZM
Date   Source Headline
21st May 202611:34 amRNSResult of AGM
5th May 20263:42 pmRNSHolding(s) in Company
24th Apr 202612:16 pmRNSNotice of AGM
13th Apr 20263:47 pmRNSBoard change
8th Apr 20267:00 amRNSQ1 Trading Update
23rd Mar 20267:00 amRNSFinal Results
12th Mar 20267:00 amRNSNotice of Full Year Results and Presentations
27th Jan 20264:08 pmRNSDirector/PDMR Shareholding
22nd Jan 20264:21 pmRNSHolding(s) in Company
15th Jan 20263:37 pmRNSDirector/PDMR Shareholding
15th Jan 20267:00 amRNSFull Year Trading Update
19th Dec 202511:00 amRNSDirector/PDMR Shareholding
19th Dec 202511:00 amRNSDirector/PDMR Shareholding
11th Dec 20254:34 pmRNSDirector/PDMR Shareholding
1st Dec 20255:14 pmRNSHolding(s) in Company
19th Nov 20257:00 amRNSChange of Registered Office
18th Nov 20253:54 pmRNSHolding(s) in Company
18th Nov 20251:13 pmRNSHolding(s) in Company
13th Nov 20255:05 pmRNSHolding(s) in Company
12th Nov 20255:30 pmRNSHolding(s) in Company
6th Nov 20253:52 pmRNSHolding(s) in Company
4th Nov 20253:44 pmRNSHolding(s) in Company
3rd Nov 20254:44 pmRNSHolding(s) in Company
3rd Nov 202512:28 pmRNSHolding(s) in Company
30th Oct 20254:55 pmRNSHolding(s) in Company
28th Oct 20254:48 pmRNSHolding(s) in Company
28th Oct 20254:43 pmRNSHolding(s) in Company
27th Oct 20253:25 pmRNSHolding(s) in Company
24th Oct 202510:52 amRNSHolding(s) in Company
21st Oct 20254:50 pmRNSHolding(s) in Company
17th Oct 20254:58 pmRNSHolding(s) in Company
16th Oct 202510:31 amRNSHolding(s) in Company
14th Oct 20253:55 pmRNSHolding(s) in Company
13th Oct 20253:11 pmRNSHolding(s) in Company
13th Oct 202510:26 amRNSHolding(s) in Company
10th Oct 202512:23 pmRNSHolding(s) in Company
9th Oct 20257:00 amRNSQ3 Trading Update
7th Oct 20259:49 amRNSHolding(s) in Company
6th Oct 20259:09 amRNSHolding(s) in Company
6th Oct 20259:09 amRNSHolding(s) in Company
2nd Oct 20254:33 pmRNSHolding(s) in Company
30th Sep 20258:50 amRNSHolding(s) in Company
29th Sep 20252:40 pmRNSHolding(s) in Company
29th Sep 20257:00 amRNSTransfer of Treasury Shares & Total Voting Rights
25th Sep 202511:11 amRNSHolding(s) in Company
18th Sep 20254:57 pmRNSHolding(s) in Company
17th Sep 20254:18 pmRNSHolding(s) in Company
17th Sep 20257:00 amRNSNon-Executive Director Appointment
15th Sep 20255:45 pmRNSHolding(s) in Company
12th Sep 20257:40 amRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.